Evidence map›Paper›PMID 31080835›Full record

ReviewBioMed research international2019

A Review of Self-Expanding Esophageal Stents for the Palliation Therapy of Inoperable Esophageal Malignancies.

Yunqing Kang

Open access · hybridAbstract readReview
In one paragraph

Review in BioMed research international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. 3D printing in palliative medicine: systematic review.BMJ supportive & palliative care · 2024
    Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Nanotechnology-based biomedical devices in the cancer diagnostics and therapy.Medical oncology (Northwood, London, England) · 2025
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Futuristic Developments and Applications in Endoluminal Stenting.Gastroenterology research and practice · 2022
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Management of tracheo-oesophageal fistula in adults.European respiratory review : an official journal of the European Respiratory Society · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Yunqing KangDepartment of Ocean and Mechanical Engineering, Florida Atlantic University, Boca Raton, FL 33431, USA.ORCID 0000-0002-9721-1837
Florida Atlantic University · US

Funding

Development of an in vitro 3D tumor tissue engineering model for esophageal cancerR03CA235244 · NCI · FLORIDA ATLANTIC UNIVERSITY · PI KANG, YUNQING · 2019 to 2020
$142k
Development of multifunctional biodegradable drug-loaded polymer stents for inoperable esophageal malignanciesR03CA201960 · NCI · FLORIDA ATLANTIC UNIVERSITY · PI KANG, YUNQING · 2016 to 2017
$142k
NCI NIH HHS R03 CA201960NCI NIH HHS R03 CA235244
6 · The paper itself

Abstract

Esophageal cancer is a very deadly disease, killing more than 15,000 people in the United States annually. Almost 400,000 new cases happen in the worldwide every year. More than 50% esophageal cancer patients are diagnosed at an advanced stage when they need an esophageal stent to open the blocked esophagus for feeding and drinking. Esophageal stents have evolved in stages over the years. Current clinically used stents commonly include stainless steel or nitinol self-expandable metallic stent (SEMS) and self-expandable plastic stent (SEPS). There are many choices of different types of stents and sizes, with fierce competition among manufacturers. However, current stent technology, whether uncovered, partially covered, fully covered SEMS or SEPS, has their own advantages to solve the dysphagia, stricture, and fistula problems, but they also cause some clinical complications. The ideal stent remains elusive. New 3D printing technique may bring new promising potential to manufacturing personalized esophageal stents. Drug-eluting stents could be the new avenue to do more than just pry open a stricture or cover a defect in the esophageal lumen, a possibility of proving local anticancer therapy simultaneously. Additionally, the lack of esophageal cancer animal models also hinders the progress of stent development. This paper reviews these topics for a comprehensive understanding of this field. In a conclusion, the ultimate goal of the future esophageal stent would have multifunction to treat the underlying conditions and restore esophageal function to near normal.

Indexed as

Equipment DesignEsophagusAlloysAnimalsConstriction, PathologicDeglutition DisordersDrug-Eluting StentsEsophageal NeoplasmsEsophageal StenosisFistulaHumansModels, AnimalPalliative CarePlasticsPrinting, Three-DimensionalStainless SteelAlloysnitinolPlasticsStainless Steel

Identifiers

PMID31080835
PMCPMC6475558
OpenAlexW2933397753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.